Hinge Health, Inc.

8-K · hnge-20260609.htm iXBRL

0001673743 2026-06-09 2026-06-09

 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549
 ________________________________________________________
 FORM 8-K
 ________________________________________________________
 CURRENT REPORT
 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): June 9, 2026
 ________________________________________________________
 Hinge Health, Inc.
 (Exact name of Registrant as Specified in Its Charter)
 ________________________________________________________

 Delaware 001-42657 81-1884841
 (State or Other Jurisdiction
of Incorporation) (Commission File Number) (IRS Employer
Identification No.)
 455 Market Street , Suite 700

 San Francisco , California
 94105
 (Address of Principal Executive Offices) (Zip Code)

 Registrant’s Telephone Number, Including Area Code: ( 415 ) 726-2206
 ________________________________________________________
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 o
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 o
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 o
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 o
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class
 Trading
Symbol(s) Name of each exchange on which registered

 Class A Common Stock, par value $0.00001 per share HNGE New York Stock Exchange

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 Emerging growth company x

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 Item 7.01 Regulation FD Disclosure.

 On June 9, 2026, Hinge Health, Inc. (the "Company") issued a press release announcing its first Investor Day at Movement and raising guidance for the second quarter 2026 and full year 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 7.01.

 The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filings.

 Item 9.01 Financial Statements and Exhibits.
 (d) The following exhibits are being filed herewith:

 Exhibit
Number Description
 99.1 Press Release, dated June 9, 2026, issued by Hinge Health, Inc.

 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 HINGE HEALTH, INC.

 Date: June 9, 2026 By:
 /s/ James Budge

 James Budge, Chief Financial Officer